ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund vs Nippon India Growth Mid Cap Fund (Mid Cap Fund- An open ended equity scheme predominantly investing in mid cap stocks)

Portfolio Overlap Analysis · Nippon vs ICICI

5.1%
Low Overlap
5 common stocks · Rank #28052 of 28,282 pairs
Fund A
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
ICICI · Sectoral - Pharma
Fund B
Nippon India Growth Mid Cap Fund (Mid Cap Fund- An open ended equity scheme predominantly investing in mid cap stocks)
Nippon · Mid Cap

Common Holdings (5)

StockWt% in ICICI Prudential Pharma HealthWt% in Nippon India Growth Mid Cap FuOverlap
Alkem Laboratories Limited
Pharmaceuticals & Biotechnology
3.83%1.49%1.49%
Lupin Limited
Pharmaceuticals & Biotechnology
5.11%1.34%1.34%
Gland Pharma Limited
Pharmaceuticals & Biotechnology
3.20%1.16%1.16%
Mankind Pharma Limited
Pharmaceuticals & Biotechnology
3.88%0.76%0.76%
Sanofi Consumer Healthcare India Limited
Pharmaceuticals & Biotechnology
0.85%0.36%0.36%

Unique to ICICI Prudential Pharma Health

  • Sun Pharmaceutical Industries Ltd.11.69%
  • Dr. Reddy's Laboratories Ltd.8.85%
  • Divi's Laboratories Ltd.8.13%
  • Cipla Ltd.7.54%
  • Aurobindo Pharma Ltd.5.71%
  • Biocon Ltd.3.64%

Unique to Nippon India Growth Mid Cap Fu

  • BSE Limited3.26%
  • Fortis Healthcare Limited2.90%
  • The Federal Bank Limited2.80%
  • Voltas Limited2.45%
  • AU Small Finance Bank Limited2.40%
  • Bharat Forge Limited2.37%
  • Ashok Leyland Limited2.11%
  • Max Financial Services Limited2.10%
  • Power Finance Corporation Limited2.09%
  • Cholamandalam Financial Holdings Limited1.98%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
5.1% (5)

Analysis

AI-generated comparative analysis coming soon.

More comparisons for ICICI Prudential Pharma Health

More comparisons for Nippon India Growth Mid Cap Fu

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.